Biden administration moves to loosen weed restrictions
The DEA confirmed… that it received the letter… the DEA is not required to follow Department of Health and Human Services recommendation.
The Biden administration’s Department of Health and Human Services is recommending that the Drug Enforcement Administration significantly loosen federal restrictions on marijuana but stopped short of advising that it should be entirely removed from the Controlled Substances Act (CSA). The health agency wants the drug moved from Schedule I to Schedule III under the CSA, potentially the biggest change in federal drug policy in decades… if the FDA decides to fully enforce regulations on the cannabis industry as it does all other Schedule III drugs, that could mean major changes for state markets. “The question that I have is whether or not the current industry will eventually be replaced by the pharmaceutical industry,” said Rachel Gillette, head of the cannabis practice at Holland & Hart, noting that ketamine and anabolic steroids are also Schedule III drugs. “I can’t go down to the corner store and buy those things.” Some state regulators, however, don’t think that much will change. “This adjusts the type of security and type of bureaucracy that exists around federal research into the substance [and] it would make it easier for companies to bring cannabis based pharmaceuticals into market,” said John Hudak, Director of Maine’s Office of Cannabis Policy, in an interview. “But in terms of administration of a state program, it has very little impact.”
Original Article (Politico):
Slightly higher times: Biden administration moves to loosen weed restrictions
Artwork Fair Use: Roger McLassus